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H I G H L I G H T S  
• Milk diversion can be useful for indicating clinical mastitis in dairy cows. 
• Reporting quality affects diagnostic value of milk diversion and reported mastitis. 
• Milk diversion episodes of 4–7 days gave optimal diagnostic properties.  
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A B S T R A C T   
The development of digital farming gives bovine mastitis research and management tools access to large datasets. 
However, the quality of registered data on clinical mastitis cases or treatments may be inadequate (e.g. due to 
missing records). In automatic milking systems, the decision to divert milk from the bulk milk tank during 
milking is registered (i.e. milk diversion indicator) for every milking and could potentially indicate a clinical 
mastitis case. This study accordingly estimated the diagnostic performance of a milk diversion indicator in 
relation to farmer-recorded clinical mastitis cases in the absence of a “gold standard”. Data on milk diversion and 
farmer-reported clinical mastitis from 3,443 lactations in 13 herds were analyzed. Each cow lactation was split 
into 30-DIM periods in which it was registered whether milk was diverted and whether clinical mastitis was 
reported. One 30-DIM period was randomly sampled for each lactation and this was the unit of analysis, this 
procedure was repeated 300 times, resulting in 300 datasets to create autocorrelation-robust results during 
analysis. We used Bayesian latent class analysis to assess the diagnostic properties of milk diversion and farmer- 
reported clinical status. We analyzed different episode lengths of milk diversion of 1 or more milk diversion days 
until 10 or more milk diversion days for two scenarios: farmers with poor-quality (51% sensitivity, 99% speci-
ficity) and high-quality (90% sensitivity, 99% specificity) mastitis registrations. The analysis was done for all 300 
datasets. The results showed that for the scenario where the quality of clinical mastitis reporting was high, the 
sensitivity was similar for milk-diversion threshold durations of 1–4 days (0.843 to 0.793 versus 0.893). Spec-
ificity increased when the number of days of milk diversion increased and was ≥98% at a milk-diversion 
threshold durations of 8 or more consecutive milk diversion days. In the scenario where the quality of clinical 
mastitis reporting was low, the sensitivity of milk diversion and reported clinical mastitis cases was similar at 
milk-diversion threshold durations of 1–7 days (0.687 to 0.448 versus 0.503 to 0.504) while specificity exceeded 
the 98% at milk-diversion threshold durations of 7 or more consecutive milk diversion days. In both scenarios, a 
milk diversion threshold duration of 4–7 days achieved the most desirable combined sensitivity and specificity. 
This study concluded that milk diversion can be a valid alternative to farmer-reported clinical mastitis as it 
performs similarly in indicating actual clinical mastitis.  
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1. Introduction 
Differences in the reported incidence of clinical mastitis in dairy 
herds could be due to actual differences in mastitis incidence, differ-
ences in farmers’ skill at observing clinical mastitis, their consistency in 
recording clinical signs, individual perceptions of the definition of 
clinical mastitis, and different thresholds for initiating treatment 
(Espetvedt et al., 2013; Vaarst et al., 2002). The underreporting of 
clinical mastitis cases has been reported by other authors (Bartlett et al., 
2001; Wolff et al., 2012) and it may bias the results of analyses that use 
clinical mastitis case data if the rate of underreporting differs between 
farmers. Currently, the main methods for assessing the number of clin-
ical cases on a farm is to ask the farmer to record the number of clinical 
cases (e.g. van den Borne et al., 2010) or to use treatment records of 
farms (Wolff et al., 2012). Both methods are time consuming and can 
result in imperfect data, as they depend on the farmer’s willingness to 
report (Wolff et al., 2012). 
A possible alternative indicator is whether the farmer changes the 
milk-diversion setting for specific cows in the automatic milking system 
(AMS) management software, to ensure that the milk from cows with 
mastitis is not transferred to the bulk tank for human consumption, but 
is discarded. If a farmer chooses to divert milk for several consecutive 
days, there is a high probability that the milk is being discarded either 
due to antibiotic treatment or other treatments requiring milk with-
drawal, or due to unfavorable milk quality. In the case of antibiotic 
treatment, farmers have a high incentive to divert the milk to avoid 
antibiotic residues and associated penalties. While treatment records 
may be incomplete or unavailable, milk diversions are consistently and 
automatically recorded by the AMS. 
Milk diversion records have been recently evaluated in combination 
with reported clinical mastitis (RCM) and AMS mastitis alerts using RCM 
as the reference standard (Bonestroo et al., 2020). To truly evaluate the 
performance of milk diversion alone as an indicator of clinical mastitis, 
we must account for the fact that farmer-RCM cases are imperfect as not 
all cases are detected and not all detected cases are reported and refrain 
from using AMS mastitis alerts in combination with milk diversion. As 
AMS mastitis alerts are highly correlated with milk diversion and 
farmer-RCM, they influence the diagnostic properties of both indicators. 
Bayesian latent class analysis has been used to evaluate diagnostic test 
properties in the absence of a “gold standard”; it allows the superiority of 
a novel test over an old test to be tested, even when the old test is the 
“gold standard” in a field (Johnson et al., 2019). Examples of its use in 
mastitis related research are comparison of the diagnostic properties of 
polymerase chain reaction testing and bacteriological culturing in 
diagnosing Streptococcus agalactiae intramammary infection in cows 
(Holmøy et al., 2018; Mahmmod et al., 2013a) and of polymerase chain 
reaction testing and bacteriological culturing in diagnosing Staphylo-
coccus aureus intramammary infection in cows (Mahmmod et al., 2013b; 
Toft et al., 2019). Bayesian latent class analysis could be used to estimate 
the sensitivity and specificity of both milk diversion and 
farmer-recorded clinical mastitis for the detection of clinical mastitis in 
AMS-managed herds. 
The aim of this study was to estimate the performance of a milk 
diversion indicator relative to farmer-recorded clinical mastitis as an 
indicator of clinical mastitis cases in AMS-managed herds, accounting 
for varying degrees of missed cases in farmer reporting. In addition, we 
wanted to investigate different thresholds in terms of consecutive milk 
diversion days to determine the milk diversion episode duration having 
the best diagnostic properties as an indicator of observed clinical 
mastitis. 
2. Materials and methods 
2.1. Data retrieval 
Table 1 gives the general description of the herds used in this study. 
The mean daily milk yield was 34.18 kg, the mean milk diversion was 
0.03 times per recorded day, and the mean farmer-RCM incidence was 
37.91 cases per 100 cow years. 
Fig. 1 gives an overview of the eligibility criteria and their effects on 
the number of observations and the steps of analysis. A retrospective 
study was conducted using data from DelPro management systems 
(DeLaval International AB, Tumba, Sweden), stored in a central DeLaval 
database. The data was retrieved from 5 Canadian, 3 American, 1 
Argentinian, 1 Italian, and 3 Dutch herds. The dataset contained AMS 
data, information on whether milk was diverted from the bulk tank, and 
farmer-detected and -registered clinical mastitis. The herds were 
managed using a VMS series AMS (DeLaval International AB, Tumba, 
Sweden). Cows were eligible to be included when at least 20 days of milk 
production observations were available from 21–50 DIM (reducing the 
dataset from 7,669 cow lactations to 4,624 cow lactations). The time 
period of the selected data was herd specific and was chosen to range 
from 15 days before the first RCM case until 15 days after the last RCM 
case, as farms in the dataset started to report clinical mastitis at different 
points in time (starting from 10 July 2018 to 28 August 2018, reducing 
the dataset from 4,624 cow lactations to 3,451 cow lactations). When a 
Table 1 
The number of milking days, number of lactations, mean diversion-day share, number of diversion days, incidence of reported clinical mastitis, number of clinical 
mastitis cases reported, mean daily milk yield, and average lactation number in each herd.  
Herd 
number 





days per day 
Number of 
diversion days 
Incidence CM a 








1 117,442 877 0.02 2,125 13.99 45 31.12 2.39 
2 28,478 186 0.06 1,597 60.24 47 25.57 2.32 
3 44,875 330 0.03 1,242 23.59 29 40.16 2.07 
4 20,286 109 0.03 618 55.78 31 33.62 2.26 
5 26,514 179 0.07 1,836 81.22 59 35.68 2.74 
6 88,040 573 0.06 5,139 12.02 29 35.81 2.36 
7 53,403 331 0.01 586 25.29 37 42.01 2.50 
8 36,281 208 0.03 1,011 53.32 53 34.78 2.30 
9 25,011 187 0.03 746 32.11 22 39.67 2.17 
10 9,690 73 0.03 281 37.67 10 31.50 2.30 
11 21,238 146 0.02 476 20.62 12 30.29 3.39 
12 20,798 146 0.01 287 33.34 19 29.65 2.68 
13 15,887 98 0.02 309 43.65 19 34.52 2.55 
Mean 39,072.54 264.85 0.03 1,250.23 37.91 31.69 34.18 2.46 
Std.dev. 31,171.52 227.00 0.02 1,318.34 20.26 15.62 4.65 0.34 
Min. 9,690 73 0.01 281 12.02 10 25.57 2.07 
Max. 117,442 877 0.07 5,139 81.22 59 42.01 3.39  
a CM = farmer-reported clinical mastitis. 
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Fig. 1. A flow diagram displaying the number of cow lactations resulting from 
the eligibility criteria in the study together with an overview of further analysis 
steps in the study. 
Table 2 
Words used to identify clinical mastitis reports and other cow’s treatments 
(subclinical mastitis, dry cow treatments, preventive treatments).  
Case reported Words 
Clinical 
mastitis 
masti, flock, mammite, mamitte, mastit, coli, staph, vlok, strep, 
aureus, hard, flok, clot, swollen, grum, enflure, blood, sang, 
arcanobact, entero, lait texture anormal, positif, enflé, rosee, 




sub, no, vac, lysigin, idocolina, estreptopendiben, hardware, 
négatif, feet, foot, leg, eye, breath, DCT, dry cow, velage, sabot  
Fig. 2. Illustration of the aggregation procedure used to align milk diversions with reported clinical mastitis cases as indicated by a time series divided into 30-day 
observation time units, with black vertical lines above the central line (i.e. milk diversion higher than milk-diversion-day threshold X within the 30-day observation 
time unit) and black vertical lines below the central line (i.e. reported clinical mastitis case within the 30-day observation time unit). 
Table 3 





Farmer-reported clinical case 
positive 
A B 
Farmer-reported clinical case 
negative 
C D  
Table 4 
Medians of the 5%, 50%, and 95% percentile of the 300 fitted models for the 
different prevalence parameters of population 1 (cows with lower milk pro-
duction) and population 2 (cows with higher milk production) in the model for 
differing milk-diversion-day thresholds and differing priors reflecting poor 
farmer clinical mastitis reporting (mode of sensitivity 51% and mode of speci-
ficity 99%) and good farmer clinical mastitis reporting (mode of sensitivity 90% 
and mode of specificity 99%).  
Milk-diversion-day 
threshold 
Prevalence population 1 Prevalence population 2 
Set of models assuming poor clinical mastitis reporting quality 
DIVa ≥ 1 0.011 | 0.019 | 0.028 0.022 | 0.031 | 0.040 
DIV ≥ 2 0.011 | 0.020 | 0.028 0.022 | 0.032 | 0.040 
DIV ≥ 3 0.011 | 0.019 | 0.028 0.021 | 0.030 | 0.039 
DIV ≥ 4 0.010 | 0.019 | 0.027 0.020 | 0.029 | 0.038 
DIV ≥ 5 0.009 | 0.018 | 0.026 0.019 | 0.028 | 0.037 
DIV ≥ 6 0.009 | 0.017 | 0.025 0.019 | 0.028 | 0.036 
DIV ≥ 7 0.008 | 0.016 | 0.024 0.019 | 0.027 | 0.035 
DIV ≥ 8 0.008 | 0.015 | 0.023 0.019 | 0.026 | 0.035 
DIV ≥ 9 0.009 | 0.016 | 0.023 0.019 | 0.027 | 0.035 
DIV ≥ 10 0.008 | 0.015 | 0.022 0.020 | 0.028 | 0.036 
Set of models assuming good clinical mastitis reporting quality 
DIV ≥ 1 0.005 | 0.010 | 0.014 0.013 | 0.018 | 0.023 
DIV ≥ 2 0.005 | 0.010 | 0.014 0.013 | 0.019 | 0.023 
DIV ≥ 3 0.005 | 0.010 | 0.014 0.013 | 0.018 | 0.023 
DIV ≥ 4 0.005 | 0.009 | 0.014 0.012 | 0.018 | 0.022 
DIV ≥ 5 0.005 | 0.009 | 0.013 0.012 | 0.017 | 0.022 
DIV ≥ 6 0.005 | 0.009 | 0.013 0.012 | 0.017 | 0.022 
DIV ≥ 7 0.005 | 0.008 | 0.013 0.012 | 0.016 | 0.021 
DIV ≥ 8 0.004 | 0.008 | 0.013 0.012 | 0.016 | 0.021 
DIV ≥ 9 0.005 | 0.009 | 0.013 0.013 | 0.017 | 0.021 
DIV ≥ 10 0.005 | 0.008 | 0.012 0.013 | 0.017 | 0.022  
a DIV = milk-diversion-day threshold in number of days when milk was 
diverted from the bulk tank. 
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gap of 30 milking days or more occurred within a lactation, we removed 
the rest of the lactation (reducing the dataset from 3,451 cow lactations 
to 3,443 cow lactations). The resulting dataset had records from 27 June 
2018 until 25 July 2019. From every lactation, we removed the first 5 
DIM, as such milk is usually not used for consumption and data before 5 
DIM were also mostly unavailable. Missing daily observations occurred 
when a cow did not visit the AMS on a specific day. Missing values were 
regarded as diversions when the last known value was a milk diversion 
and the next known value was also a milk diversion, and as non-diverted 
otherwise. 
2.2. Test methods and case identification 
The first test method is RCM in which farmers actively reported 
clinical mastitis in their management system. To identify RCM cases, 
search queries were specified to collect cases in the DelPro database. A 
case of mastitis was reported as clinical mastitis, mastitis, or signs of 
mastitis (e.g. flocks or clots in the milk). A case of RCM was considered 
as either when directly reported as clinical mastitis by the farmer or 
when the case was not specifically indicated by the farmer as clinical 
mastitis but the farmer’s remarks contained any of the words or parts 
thereof in Table 2 for a cow. 
Each unique farmers’ remark was manually screened and translated 
to English using translation software (Google Translate) when we con-
structed the queries. From the resulting management program records, 
we excluded the treatment of subclinical mastitis or treatments without 
any reported clinical mastitis or signs of mastitis from the results of the 
query above. We also excluded registrations with remarks indicating dry 
cow treatments, preventive treatments such as vaccinations, or other 
diseases using the other treatments in Table 2. 
The resulting reported clinical mastitis cases were regarded as 
separate episodes when there was an interval of at least 8 days between 
two clinical mastitis observations (International Dairy Federation, 
2011). 
The second test method was milk diversion in which milk was 
diverted from the bulk tank with consumable milk for multiple 
consecutive days. Identifying a milk diversion case, 10 different 
thresholds for the duration of a milk diversion episode were applied, i.e. 
with thresholds ranging from 1 or more milk diversion days to 10 or 
more milk diversion days, as we determined that 90% of the milk 
Table 5 
Medians of the 5%, 50%, and 95% percentile of the 300 fitted models for the different parameters in the model at differing milk-diversion-day thresholds and for 
differing priors reflecting poor farmer clinical mastitis reporting (mode of sensitivity 51% and mode of specificity 99%) and good farmer clinical mastitis reporting 
(mode of sensitivity 90% and mode of specificity 99%).  
Milk-diversion-day threshold SeMD b SeRCM c SpMD d SpRCM e Covariance sensitivity Covariance specificity 
Set of models assuming poor clinical mastitis reporting quality  
DIVa ≥ 1 0.542 | 0.687 | 0.830 0.470 | 0.503 | 0.536 0.903 | 0.909 | 
0.916 
0.988 | 0.993 | 0.996 0.033 | 0.087 | 0.152 0.002 | 0.005 | 0.009 
DIV ≥ 2 0.538 | 0.680 | 0.823 0.470 | 0.503 | 0.536 0.949 | 0.956 | 
0.962 
0.988 | 0.993 | 0.997 0.033 | 0.085 | 0.149 0.002 | 0.005 | 0.009 
DIV ≥ 3 0.522 | 0.656 | 0.809 0.471 | 0.504 | 0.537 0.959 | 0.965 | 
0.972 
0.988 | 0.993 | 0.996 0.036 | 0.091 | 0.154 0.002 | 0.005 | 0.010 
DIV ≥ 4 0.490 | 0.623 | 0.779 0.470 | 0.504 | 0.536 0.963 | 0.969 | 
0.975 
0.988 | 0.992 | 0.996 0.037 | 0.091 | 0.148 0.002 | 0.006 | 0.010 
DIV ≥ 5 0.449 | 0.578 | 0.734 0.470 | 0.504 | 0.536 0.968 | 0.974 | 
0.980 
0.987 | 0.992 | 0.996 0.038 | 0.088 | 0.143 0.002 | 0.006 | 0.010 
DIV ≥ 6 0.404 | 0.532 | 0.694 0.470 | 0.503 | 0.537 0.971 | 0.976 | 
0.982 
0.987 | 0.991 | 0.995 0.038 | 0.088 | 0.139 0.002 | 0.006 | 0.010 
DIV ≥ 7 0.327 | 0.448 | 0.596 0.470 | 0.504 | 0.537 0.973 | 0.978 | 
0.983 
0.987 | 0.991 | 0.994 0.032 | 0.073 | 0.121 0.002 | 0.006 | 0.009 
DIV ≥ 8 0.275 | 0.392 | 0.553 0.470 | 0.504 | 0.537 0.976 | 0.981 | 
0.985 
0.987 | 0.990 | 0.994 0.028 | 0.065 | 0.111 0.002 | 0.006 | 0.009 
DIV ≥ 9 0.232 | 0.343 | 0.488 0.471 | 0.504 | 0.537 0.980 | 0.984 | 
0.988 
0.987 | 0.990 | 0.994 0.025 | 0.059 | 0.099 0.002 | 0.005 | 0.008 
DIV ≥ 10 0.156 | 0.262 | 0.397 0.470 | 0.503 | 0.536 0.983 | 0.986 | 
0.990 
0.987 | 0.990 | 0.993 0.018 | 0.044 | 0.078 0.002 | 0.005 | 0.007 
Set of models assuming good clinical mastitis reporting quality  
DIV ≥ 1 0.766 | 0.843 | 0.910 0.872 | 0.893 | 0.912 0.900 | 0.905 | 
0.910 
0.988 | 0.993 | 0.996 0.015 | 0.034 | 0.057 0.002 | 0.005 | 0.009 
DIV ≥ 2 0.761 | 0.839 | 0.909 0.872 | 0.893 | 0.912 0.946 | 0.951 | 
0.955 
0.988 | 0.993 | 0.996 0.014 | 0.033 | 0.056 0.002 | 0.005 | 0.010 
DIV ≥ 3 0.746 | 0.829 | 0.900 0.872 | 0.893 | 0.912 0.956 | 0.961 | 
0.965 
0.988 | 0.993 | 0.996 0.015 | 0.034 | 0.056 0.002 | 0.005 | 0.010 
DIV ≥ 4 0.699 | 0.793 | 0.871 0.872 | 0.893 | 0.912 0.961 | 0.965 | 
0.969 
0.987 | 0.992 | 0.996 0.015 | 0.033 | 0.055 0.002 | 0.006 | 0.010 
DIV ≥ 5 0.646 | 0.748 | 0.836 0.873 | 0.894 | 0.912 0.966 | 0.970 | 
0.974 
0.987 | 0.991 | 0.995 0.014 | 0.032 | 0.052 0.002 | 0.006 | 0.010 
DIV ≥ 6 0.580 | 0.696 | 0.791 0.873 | 0.894 | 0.913 0.969 | 0.973 | 
0.977 
0.987 | 0.991 | 0.995 0.014 | 0.030 | 0.050 0.002 | 0.006 | 0.010 
DIV ≥ 7 0.457 | 0.594 | 0.710 0.873 | 0.894 | 0.913 0.972 | 0.976 | 
0.980 
0.987 | 0.991 | 0.995 0.011 | 0.025 | 0.043 0.003 | 0.006 | 0.009 
DIV ≥ 8 0.394 | 0.529 | 0.645 0.873 | 0.894 | 0.913 0.975 | 0.979 | 
0.982 
0.987 | 0.991 | 0.994 0.010 | 0.023 | 0.039 0.003 | 0.006 | 0.009 
DIV ≥ 9 0.331 | 0.464 | 0.584 0.873 | 0.894 | 0.913 0.979 | 0.982 | 
0.985 
0.988 | 0.991 | 0.995 0.008 | 0.020 | 0.035 0.002 | 0.005 | 0.007 
DIV ≥ 10 0.210 | 0.343 | 0.469 0.873 | 0.894 | 0.913 0.982 | 0.985 | 
0.987 
0.988 | 0.991 | 0.994 0.006 | 0.014 | 0.027 0.002 | 0.005 | 0.007  
a DIV = milk-diversion-day threshold in number of days when milk was diverted from the bulk tank; 
b SeMD = sensitivity, milk diversion; 
c SeRCM = sensitivity, reported clinical mastitis; 
d SpMD = specificity milk diversion; 
e SpRCM = specificity reported clinical mastitis. 
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diversion periods were equal to or shorter than 10 days and we wanted 
to include every possible threshold. 
Next, an aggregation procedure, shown in Fig. 2, was applied to align 
in time the classification of the milk diversion variable and the farmer- 
RCM case variable, because a milk diversion could have occurred earlier 
or later than the clinical mastitis registration. To account for differences 
in DIM between the milk diversion episode and the RCM case, individual 
cow milkings during a lactation were grouped into observation time 
units of 30 DIM (i.e. 5–35, 35–65, 65–95, and so forth up to 315 DIM). 
For each 30-day observation time unit, when 10 or more milkings were 
recorded, it was noted whether there was a recorded clinical mastitis 
case as well as a start of a milk diversion episode. The minimum number 
of milkings within the 30-day observation time units was chosen due to 
the maximum milk diversion threshold of 10 days or more. 
2.3. Analysis 
Using the collected data, the diagnostic properties of milk diversion 
and reported cases of clinical mastitis were evaluated using Bayesian 
latent class analysis. We used a two-test multiple-population model (Hui 
and Walter, 1980) for each milk diversion threshold. To obtain sub-
populations, we divided the data into two equally sized subpopulations 
using the median of mean daily milk yield of each lactation during 
21–50 DIM of the cow. The milk yield variable was chosen as differences 
in clinical mastitis incidence can be expected between cows with high 
versus low milk yields, as a high milk yield is a risk factor for clinical 
mastitis (Barnouin et al., 2005; Suriyasathaporn et al., 2000; Waage 
et al., 1998). Furthermore, higher parity cows tend to have higher milk 
production and a higher parity is also a cow risk factor for clinical 
mastitis incidence (Steeneveld et al., 2008). 
It was not possible to include all 30-DIM windows in one analysis 
because of autocorrelation between the periods belonging to the same 
lactation could occur and bias our estimates of the diagnostic properties. 
Instead, we randomly sampled 1 30-DIM window from each lactation to 
include in the analysis. 
During preliminary analysis, we found that the estimated specificity 
and sensitivity parameters differed widely between the different 
Bayesian Latent Class Analysis models when we fitted the models on 
different randomly sampled datasets. This was due to a limited number 
of cases of milk diversion negative–reported clinical positive cases (B in 
Table 3 that indicates the cross tabulation) in the dataset. Therefore, the 
effect on the estimated parameters could be sizable when we randomly 
sampled 30d periods and this explained the variation in estimated pa-
rameters. Randomly sampling a large number of times would allow us to 
incorporate the uncertainty of artificially sampling lactations, attain 
more robust results, and give insight into the overall distribution of the 
Fig. A1. Graphs indicating the form of the prior distributions for all the parameters in models as used in this study.  
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sensitivity and specificity parameters. Therefore, we created 300 
randomly sampled datasets. To check whether this was sufficient, we 
compared it to the model results at 200 randomly sampled datasets and 
determined that the differences in estimated median sensitivity and 
specificity parameters between the 200 and 300 fits were less than 0.02 
for all milk diversion thresholds and 2 prior groups. 
Furthermore, we used a model in which the milk diversion and re-
ported cases of clinical mastitis were conditionally dependent. In a 
standard Bayesian latent class analysis, conditional independence is 
assumed (Kostoulas et al., 2017), which would mean that the farmer was 
no more likely to divert milk when the farmer-RCM, and vice versa, 
regardless of whether the cow actually suffered from clinical mastitis. 
This is unrealistic, as both milk diversion and RCM rely on the same 
mechanism for the detection of clinical mastitis. 
The model used a cross-tabulation (see Table 3) as a basis for each of 
the two milk production subpopulations. 
Each outcome combination (A, B, C, D) was modelled using a 
multinomial distribution with four possible outcomes, with four sepa-
rate probabilities (Pi,a, Pi,b, Pi,c, Pi,d). These probabilities were specific to 
each population i (two milk production groups) and were functions of 
population-specific prevalence (the proportion of the positive samples in 
the total population) parameters, sensitivity (the proportion of the 
rightly identified positive samples in the total number of positive sam-
ples) parameters of recorded clinical mastitis cases (SeRCM) and milk 
diversion (SeMD), and specificity (the proportion of the rightly identified 
negative samples in the total number of negative samples) parameters of 
recorded clinical mastitis cases (SpRCM) and milk diversion (SpMD). The 
associations between sensitivity and specificity parameters were esti-
mated by fitting two covariance parameters (covSE and covSP) and 
specifying the association between the sensitivities and the specificities, 
in accordance with the fixed-effects model described by Dendukuri and 
Joseph (2001). The exact model is defined below: 
Table B1 
Twenty-fifth percentile of the 5%, 50%, and 95% percentile of the 300 fitted models for the different prevalence parameters of population 1 (cows with lower milk 
production) and population 2 (cows with higher milk production) in the model for differing milk-diversion-day thresholds and differing priors reflecting poor farmer 
clinical mastitis reporting (mode of sensitivity 51% and mode of specificity 99%) and good farmer clinical mastitis reporting (mode of sensitivity 90% and mode of 
specificity 99%).  
Milk-diversion-day threshold Prevalence population 1 Prevalence population 2 
Set of models assuming poor clinical mastitis reporting quality 
DIVa ≥ 1 0.009 | 0.017 | 0.025 0.018 | 0.028 | 0.036 
DIV ≥ 2 0.009 | 0.017 | 0.025 0.018 | 0.028 | 0.036 
DIV ≥ 3 0.009 | 0.017 | 0.025 0.017 | 0.027 | 0.036 
DIV ≥ 4 0.007 | 0.016 | 0.024 0.017 | 0.026 | 0.034 
DIV ≥ 5 0.007 | 0.014 | 0.022 0.016 | 0.025 | 0.033 
DIV ≥ 6 0.007 | 0.014 | 0.022 0.016 | 0.024 | 0.033 
DIV ≥ 7 0.006 | 0.013 | 0.021 0.016 | 0.023 | 0.032 
DIV ≥ 8 0.006 | 0.012 | 0.020 0.015 | 0.023 | 0.031 
DIV ≥ 9 0.007 | 0.013 | 0.020 0.015 | 0.023 | 0.031 
DIV ≥ 10 0.007 | 0.012 | 0.019 0.015 | 0.023 | 0.032 
Set of models assuming good clinical mastitis reporting quality 
DIV ≥ 1 0.004 | 0.009 | 0.013 0.010 | 0.016 | 0.021 
DIV ≥ 2 0.004 | 0.009 | 0.013 0.010 | 0.016 | 0.021 
DIV ≥ 3 0.004 | 0.009 | 0.013 0.010 | 0.016 | 0.021 
DIV ≥ 4 0.004 | 0.008 | 0.012 0.010 | 0.015 | 0.020 
DIV ≥ 5 0.003 | 0.007 | 0.012 0.010 | 0.015 | 0.020 
DIV ≥ 6 0.004 | 0.007 | 0.012 0.010 | 0.015 | 0.020 
DIV ≥ 7 0.003 | 0.007 | 0.011 0.010 | 0.014 | 0.019 
DIV ≥ 8 0.003 | 0.007 | 0.011 0.010 | 0.014 | 0.019 
DIV ≥ 9 0.004 | 0.007 | 0.011 0.010 | 0.015 | 0.019 
DIV ≥ 10 0.004 | 0.007 | 0.010 0.010 | 0.015 | 0.020  
a DIV = milk-diversion-day threshold in number of days when milk was diverted from the bulk tank. 
Pi, a = prevalencei ∗ (SEMD ∗ SERCM + covSE) + (1 − prevalencei) ∗ ((1 − SPMD) ∗ (1 − SPRCM)+ covSP) (1)   
Pi,b = prevalencei ∗ (SEMD ∗ (1 − SERCM) − covSE) + (1 − prevalencei) ∗ ((1 − SPMD) ∗ SPRCM − covSP) (2)   
Pi, c = prevalencei ∗ ((1 − SEMD) ∗ SERCM − covSE) + (1 − prevalencei) ∗ (SPMD ∗ (1 − SPRCM) − covSP) (3)   
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Furthermore, the covariance parameters were constrained as fol-
lows: 
0 ≤ covSE ≤ min(SEMD, SERCM) − SEMD ∗ SERCM (5)  
0 ≤ covSP ≤ min(SPMD, SPRCM) − SPMD ∗ SPRCM (6) 
The constraints in (5) and (6) were implemented to ensure that SEMD 
∗SERCM + covSE and SPMD ∗ SPRCM + covSP could not be higher than SEMD, 
SERCM and SPMD, SPRCM individually. The reason for these constraints is 
that multiplying sensitivities or specificities, which are essentially 
probabilities, would create joint probabilities that could not be higher 
than the probabilities of the events separately (e.g. the probability that 
the farmer-reported status and the milk diversion indicator are both 
correct cannot exceed the probability that the farmer-reported status is 
correct). This constraint was imposed by estimating a transformed 
covariance parameter (transformed covSE, covSP) taking values from 
0 to 1 using a beta(1; 1) distribution and multiplying this by the upper 
bound of the constraints described above to form covSE and covSP, 
which were used in (1), (2), (3), and (4). 
Bayesian statistics necessitates the use of prior distributions for all 
parameters. Moreover, the conditionally dependent model implies that 
informative priors for the sensitivity and specificity of one of either milk 
diversion or RCM are required (Branscum et al., 2005). The models were 
fitted using non-informative priors, namely, beta(1; 1) for milk diversion 
sensitivity, milk diversion specificity, and the transformed covariance 
parameters between the sensitivities and specificities of milk diversion 
and recorded clinical mastitis cases. These priors were chosen as we had 
Table B2 
Twenty-fifth percentile of the 5%, 50%, and 95% percentile of the 300 fitted models for the different parameters in the model at differing milk-diversion-day thresholds 
and for differing priors reflecting poor farmer clinical mastitis reporting (mode of sensitivity 51% and mode of specificity 99%) and good farmer clinical mastitis 
reporting (mode of sensitivity 90% and mode of specificity 99%).  
Milk-diversion-day threshold SeMD b SeRCM c SpMD d SpRCM e Covariance sensitivity Covariance specificity 
Set of models assuming poor clinical mastitis reporting quality  
DIVa ≥ 1 0.511 | 0.643 | 0.794 0.468 | 0.501 | 0.534 0.900 | 0.907 | 
0.913 
0.987 | 0.992 | 0.996 0.025 | 0.071 | 0.136 0.001 | 0.004 | 0.008 
DIV ≥ 2 0.506 | 0.631 | 0.784 0.468 | 0.501 | 0.534 0.947 | 0.954 | 
0.960 
0.987 | 0.992 | 0.996 0.026 | 0.072 | 0.135 0.002 | 0.004 | 0.008 
DIV ≥ 3 0.486 | 0.609 | 0.764 0.468 | 0.501 | 0.534 0.957 | 0.963 | 
0.970 
0.987 | 0.992 | 0.996 0.027 | 0.074 | 0.136 0.002 | 0.004 | 0.008 
DIV ≥ 4 0.447 | 0.566 | 0.724 0.468 | 0.501 | 0.535 0.961 | 0.967 | 
0.973 
0.986 | 0.991 | 0.995 0.028 | 0.074 | 0.134 0.002 | 0.005 | 0.009 
DIV ≥ 5 0.399 | 0.521 | 0.673 0.469 | 0.502 | 0.535 0.965 | 0.971 | 
0.977 
0.986 | 0.991 | 0.995 0.029 | 0.074 | 0.130 0.002 | 0.005 | 0.009 
DIV ≥ 6 0.352 | 0.457 | 0.599 0.469 | 0.502 | 0.535 0.969 | 0.975 | 
0.980 
0.986 | 0.990 | 0.994 0.029 | 0.072 | 0.125 0.002 | 0.005 | 0.008 
DIV ≥ 7 0.258 | 0.366 | 0.493 0.468 | 0.501 | 0.534 0.971 | 0.976 | 
0.981 
0.986 | 0.990 | 0.993 0.026 | 0.064 | 0.110 0.002 | 0.005 | 0.008 
DIV ≥ 8 0.206 | 0.314 | 0.441 0.468 | 0.501 | 0.534 0.974 | 0.978 | 
0.983 
0.986 | 0.989 | 0.993 0.022 | 0.055 | 0.098 0.002 | 0.005 | 0.008 
DIV ≥ 9 0.167 | 0.262 | 0.382 0.469 | 0.501 | 0.535 0.978 | 0.982 | 
0.986 
0.986 | 0.989 | 0.993 0.020 | 0.050 | 0.087 0.002 | 0.004 | 0.007 
DIV ≥ 10 0.099 | 0.182 | 0.282 0.469 | 0.502 | 0.535 0.981 | 0.984 | 
0.988 
0.986 | 0.989 | 0.992 0.014 | 0.035 | 0.065 0.002 | 0.004 | 0.006 
Set of models assuming good clinical mastitis reporting quality  
DIV ≥ 1 0.726 | 0.812 | 0.885 0.871 | 0.892 | 0.911 0.897 | 0.902 | 
0.907 
0.986 | 0.992 | 0.996 0.013 | 0.032 | 0.055 0.001 | 0.004 | 0.008 
DIV ≥ 2 0.719 | 0.805 | 0.881 0.871 | 0.892 | 0.911 0.944 | 0.949 | 
0.953 
0.987 | 0.992 | 0.996 0.013 | 0.032 | 0.055 0.002 | 0.004 | 0.008 
DIV ≥ 3 0.706 | 0.797 | 0.873 0.871 | 0.893 | 0.911 0.954 | 0.959 | 
0.963 
0.987 | 0.992 | 0.996 0.014 | 0.032 | 0.055 0.002 | 0.004 | 0.008 
DIV ≥ 4 0.635 | 0.751 | 0.836 0.872 | 0.893 | 0.912 0.958 | 0.963 | 
0.967 
0.986 | 0.991 | 0.995 0.014 | 0.031 | 0.052 0.002 | 0.005 | 0.009 
DIV ≥ 5 0.566 | 0.696 | 0.797 0.872 | 0.893 | 0.912 0.964 | 0.968 | 
0.972 
0.986 | 0.990 | 0.995 0.013 | 0.029 | 0.049 0.002 | 0.005 | 0.009 
DIV ≥ 6 0.508 | 0.644 | 0.743 0.873 | 0.893 | 0.912 0.968 | 0.972 | 
0.976 
0.986 | 0.990 | 0.995 0.012 | 0.028 | 0.046 0.002 | 0.005 | 0.008 
DIV ≥ 7 0.380 | 0.528 | 0.642 0.873 | 0.894 | 0.912 0.970 | 0.974 | 
0.978 
0.986 | 0.990 | 0.994 0.010 | 0.022 | 0.039 0.002 | 0.005 | 0.008 
DIV ≥ 8 0.303 | 0.456 | 0.575 0.873 | 0.894 | 0.912 0.974 | 0.977 | 
0.980 
0.986 | 0.990 | 0.994 0.008 | 0.019 | 0.034 0.002 | 0.005 | 0.008 
DIV ≥ 9 0.251 | 0.391 | 0.510 0.873 | 0.894 | 0.912 0.978 | 0.981 | 
0.984 
0.986 | 0.990 | 0.994 0.007 | 0.016 | 0.030 0.002 | 0.004 | 0.007 
DIV ≥ 10 0.153 | 0.273 | 0.385 0.873 | 0.894 | 0.912 0.981 | 0.983 | 
0.986 
0.987 | 0.990 | 0.993 0.004 | 0.011 | 0.022 0.002 | 0.004 | 0.006  
a DIV = milk-diversion-day threshold in number of days when milk was diverted from the bulk tank; 
b SeMD = sensitivity, milk diversion; 
c SeRCM = sensitivity, reported clinical mastitis; 
d SpMD = specificity milk diversion; 
e SpRCM = specificity reported clinical mastitis. 
Pi, d = prevalencei ∗ ((1 − SEMD) ∗ (1 − SERCM)+ covSE) + (1 − prevalencei) ∗ (SPMD ∗ SPRCM + covSP) (4)   
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no prior information on the sensitivity and specificity of milk diversion 
or on the association between milk diversion and the reporting of clin-
ical mastitis. For prevalence, we set a uniform prior that could contain 
values from 0 to 0.5 (uniform(0; 0.5)), as we assumed that the preva-
lence of clinical mastitis could not exceed 50%. This was done to avoid 
the label switching problem (Stephens, 2000), in which a healthy case 
would be defined as a positive case (i.e. the number 1) by the model 
rather than a positive case being defined as a clinical mastitis case, with 
this definition switching between runs. Such switching between runs 
leads to erroneous results. For the sensitivity and specificity of 
farmer-recorded clinical mastitis cases, we set informative priors. We 
used the epi.betabuster function of the epiR (Stevenson et al., 2013) in R 
3.6.1 (R Core Team, 2018) to obtain parameters for these informative 
prior (beta) distributions using a mode and a probability that the 
parameter is higher or lower than a set value. Specifically, for the 
specificity of farmer-RCM, it was assumed that the farmer rarely mis-
identified a non-clinical mastitis case as a clinical case, since clinical 
mastitis is visible. As a result, the prior for the specificity of farmer-RCM 
was set to a mode of 99% and a confidence of 90% that the specificity 
would exceed 90%. This resulted in a beta(11.049;1.101505) distribu-
tion. For sensitivity, limited information is available on the diagnostic 
abilities of farmers to detect clinical mastitis. Due to the limited infor-
mation on larger groups of people, we created two sets of models using 
two different sensitivity priors to reflect two scenarios (Wolff et al., 
2012), scenario 1 is as a poor clinical mastitis reporting-quality, and 
scenario 2 is a good clinical mastitis reporting-quality. In a study of 
sensitivity in reporting clinical mastitis cases per Nordic country, Wolff 
et al. (2012) found that Finland had the lowest sensitivity of 0.51 (CI: 
0.43–0.59) and Denmark had the highest sensitivity of 0.90 (CI: 
0.87–0.93). For the set of models assuming poor clinical mastitis 
reporting quality, we assumed a mode of 51% and a confidence of 95% 
that the sensitivity would exceed 43%, in line with the reported sensi-
tivity for Finland (Wolff et al., 2012). This resulted in a beta(53.82; 
51.74863) distribution. For the set of models assuming good clinical 
mastitis reporting quality, we assumed a mode of 90% and a confidence 
of 95% that the sensitivity would exceed 87% (Wolff et al., 2012). This 
resulted in a beta(100; 12) distribution. All prior distributions are 
visualized in Appendix A. The posterior distributions of the sensitivity 
and specificity of both indicators at each threshold for milk diversion 
duration were estimated using Markov chain Monte Carlo methods. 
The models (300 datasets times 10 milk diversion thresholds times 2 
reporting quality scenarios = 6000 models) were estimated using JAGS 
(Plummer, 2003), with RJAGS (Plummer, 2013) as an interface with an 
adaptation phase of 5,000 samples and a burn-in of 100,000 samples 
without thinning. This number of samples for burn-in was chosen as a 
substantial number of models did not converge with lower burn-in. 
Thinning was not performed as it is not necessarily useful as we were 
not constrained by computer memory limitations (Link and Eaton, 
2012). This number of samples for burn-in was chosen as a substantial 
number of models did not converge with lower burn-in. Next, 100,000 
samples were drawn from each model. Two Markov chains were run for 
each model to determine whether both chains independently converged 
on the same distributions. This was checked by using the Gelman–Rubin 
convergence diagnostic (Gelman and Rubin, 1992) with a confidence 
interval of 0.95 where it was tracked when the diagnostic was equal or 
above 1.01. If this was the case for any of the 6000 models, this model 
was rerun with another random seed until it converged according to the 
Gelman–Rubin convergence diagnostic (Gelman and Rubin, 1992). This 
measure was chosen as it returns a single value that can be compared to 
a value (1.01) for each and it uses multiple independent chains to 
determine convergence and it is used by others in the context of 
Bayesian Latent Class analysis (Kostoulas et al., 2017; Mahmmod et al., 
2013b, 2013a). 
To summarize the results of the 300 models, we calculated the me-
dian (and the 25th and 75th percentiles in Appendix B) of summary 
statistics (the 95% credible interval and the median) of each model 
parameter in the 300 models and reported them as such in the Results 
section. 
3. Results 
Table 4 gives the median population-specific prevalence parameters 
of the 300 models at different thresholds for milk diversion duration and 
the two milk production level subpopulations. The estimated (“true”) 
prevalence of clinical mastitis decreased when the milk-diversion-day 
threshold increased in all scenarios. Table 5 shows the median sensi-
tivity and specificity of milk diversion and RCM of the 300 models, while 
the summary statistics of the 25th and 75th percentiles of the 300 models 
can be found in Appendix B. SeMD generally decreased with increasing 
milk-diversion-day threshold in both poor and good clinical mastitis 
reporting-quality scenarios, while SpMD increased with an increasing 
milk-diversion-day threshold. SeMD and SeRCM were similar at 1–7 (50th 
percentile of SeMD within 10% of SeRCM or higher) milk diversion days in 
the poor reporting-quality scenario and at 1–4 milk diversion days in the 
good reporting-quality scenario. The 95% credible interval of SeMD 
ranged from 0.542–0.830 to 0.156 - 0.397 in the poor clinical mastitis 
reporting quality models for the 1 or more milk diversion days and 10 or 
more milk diversion days threshold respectively, and from 0.766–0.910 
to 0.210–0.469 in the good clinical mastitis reporting quality models. 
The 95% credible interval of SeRCM ranged from 0.470–0.536 to 
0.471–0.537 in the poor clinical mastitis reporting quality models and 
from 0.872–0.912 to 0.873–0.913 in the good clinical mastitis reporting 
quality models. At more than 4 and 7 milk diversion days, SeMD 
decreased substantially for the good and poor reporting-quality sce-
narios. However, SpMD was low at thresholds shorter than 7 days of milk 
diversion relative to SpMD at higher thresholds. SpMD was not substan-
tially greater than SpRCM at any milk-diversion-day threshold in any 
scenario, although SpMD did come relatively close to approximately 
0.990 and close to SpRCM (50th percentile of SpMD in Table 5 was more 
than 98% at a milk-diversion-day threshold of 8 to 10 or more milk 
Table B3 
Seventy-fifth percentile of the 5%, 50%, and 95% percentile of the 300 fitted 
models for the different prevalence parameters of population 1 (cows with lower 
milk production) and population 2 (cows with higher milk production) in the 
model for differing milk-diversion-day thresholds and differing priors reflecting 
poor farmer clinical mastitis reporting (mode of sensitivity 51% and mode of 
specificity 99%) and good farmer clinical mastitis reporting (mode of sensitivity 
90% and mode of specificity 99%).  
Milk-diversion-day 
threshold 
Prevalence population 1 Prevalence population 2 
Set of models assuming poor clinical mastitis reporting quality 
DIVa ≥ 1 0.012 | 0.022 | 0.031 0.026 | 0.036 | 0.045 
DIV ≥ 2 0.012 | 0.022 | 0.031 0.027 | 0.036 | 0.044 
DIV ≥ 3 0.013 | 0.023 | 0.031 0.025 | 0.035 | 0.044 
DIV ≥ 4 0.012 | 0.022 | 0.031 0.024 | 0.033 | 0.042 
DIV ≥ 5 0.011 | 0.021 | 0.030 0.023 | 0.032 | 0.041 
DIV ≥ 6 0.011 | 0.020 | 0.029 0.022 | 0.032 | 0.040 
DIV ≥ 7 0.010 | 0.019 | 0.028 0.022 | 0.031 | 0.040 
DIV ≥ 8 0.010 | 0.019 | 0.027 0.022 | 0.030 | 0.039 
DIV ≥ 9 0.011 | 0.018 | 0.026 0.023 | 0.031 | 0.040 
DIV ≥ 10 0.010 | 0.018 | 0.025 0.025 | 0.033 | 0.041 
Set of models assuming good clinical mastitis reporting quality 
DIV ≥ 1 0.006 | 0.011 | 0.016 0.016 | 0.021 | 0.026 
DIV ≥ 2 0.006 | 0.011 | 0.016 0.016 | 0.021 | 0.026 
DIV ≥ 3 0.006 | 0.011 | 0.016 0.016 | 0.021 | 0.026 
DIV ≥ 4 0.006 | 0.011 | 0.015 0.015 | 0.020 | 0.025 
DIV ≥ 5 0.005 | 0.010 | 0.015 0.014 | 0.020 | 0.025 
DIV ≥ 6 0.005 | 0.010 | 0.015 0.014 | 0.019 | 0.024 
DIV ≥ 7 0.005 | 0.010 | 0.014 0.014 | 0.019 | 0.024 
DIV ≥ 8 0.005 | 0.009 | 0.014 0.014 | 0.019 | 0.024 
DIV ≥ 9 0.005 | 0.010 | 0.014 0.015 | 0.019 | 0.024 
DIV ≥ 10 0.005 | 0.009 | 0.014 0.015 | 0.020 | 0.024  
a DIV = milk-diversion-day threshold in number of days when milk was 
diverted from the bulk tank. 
J. Bonestroo et al.                                                                                                                                                                                                                              
Livestock Science 253 (2021) 104698
9
diversion days and 9 to 10 or more milk diversion days for the poor and 
good mastitis reporting-quality scenarios, respectively). The 95% cred-
ible interval of SpMD in Table 5 ranged from 0.903-0.916 to 0.983–0.990 
in the poor clinical mastitis reporting quality models, and from 0.900 - 
0.910 to 0.982–0.987 in the good clinical mastitis reporting quality 
models. The 95% credible interval of SpRCM ranged from 0.987–0.993 to 
0.988–0.996 in the poor clinical mastitis reporting quality models and 
from 0.987–0.994 to 0.988–0.996 in the good clinical mastitis reporting 
quality models. The covariance between SpMD and SpRCM did not differ 
substantially between all models. In contrast, the covariance between 
SeMD and SeRCM differed and was substantially greater in the poor 
reporting-quality scenario, both in median level as well as the variation 
indicated in the 95% credible interval. A high covariance between 
sensitivities indicates that farmers tended to divert milk when they re-
ported clinical mastitis, and vice versa, regardless of whether the cow 
actually had mastitis. Furthermore, in both scenarios, the covariance 
between sensitivity parameters decreased when the milk-diversion-day 
threshold increased. 
4. Discussion 
To our knowledge, this is the first study investigating the accuracy of 
milk diversion as a mastitis indicator in relation to the accuracy of 
farmers’ registration of clinical mastitis. Obtaining insight into the ac-
curacy of milk diversion is useful as it is commonly available in AMS 
management software data and it could be an appropriate indicator of 
farmer-RCM cases, especially when there is no such data or data of low 
reporting quality. We used different thresholds on consecutive days of 
diverted milk and found that milk diversion is similar in sensitivity to 
farmer-RCM cases at a milk-diversion-day threshold duration of 1 to 4 
days. However, at a milk-diversion-day threshold of 1 to 4 days, it can be 
questioned whether specificity is high enough to warrant the use of the 
threshold. A milk diversion specificity of more than 98% can be reached 
at a milk-diversion-day threshold of 8 to 10 or more milk diversion days 
and 9 to 10 or more milk diversion days for the poor and good mastitis 
reporting-quality scenarios, respectively. A high sensitivity of milk 
diversion relative to reported clinical cases can be reached at lower milk- 
diversion-day thresholds, but at the cost of lower specificity. There is, as 
always, a tradeoff between sensitivity and specificity when changing the 
Table B4 
Seventy-fifth percentile of the 5%, 50%, and 95% percentile of the 300 fitted models for the different parameters in the model at differing milk-diversion-day 
thresholds and for differing priors reflecting poor farmer clinical mastitis reporting (mode of sensitivity 51% and mode of specificity 99%) and good farmer clin-
ical mastitis reporting (mode of sensitivity 90% and mode of specificity 99%).  
Milk-diversion-day threshold SeMD b SeRCM c SpMD d SpRCM e Covariance sensitivity Covariance specificity 
Set of models assuming poor clinical mastitis reporting quality  
DIVa ≥ 1 0.578 | 0.730 | 0.864 0.471 | 0.504 | 0.537 0.905 | 0.912 | 
0.919 
0.990 | 0.994 | 0.997 0.045 | 0.108 | 0.168 0.002 | 0.005 | 0.010 
DIV ≥ 2 0.575 | 0.726 | 0.859 0.472 | 0.505 | 0.538 0.951 | 0.957 | 
0.964 
0.990 | 0.994 | 0.997 0.045 | 0.108 | 0.169 0.002 | 0.006 | 0.010 
DIV ≥ 3 0.562 | 0.706 | 0.843 0.473 | 0.506 | 0.539 0.961 | 0.967 | 
0.974 
0.989 | 0.994 | 0.997 0.050 | 0.115 | 0.171 0.002 | 0.006 | 0.011 
DIV ≥ 4 0.529 | 0.676 | 0.821 0.472 | 0.505 | 0.538 0.965 | 0.971 | 
0.978 
0.989 | 0.993 | 0.996 0.050 | 0.114 | 0.165 0.002 | 0.007 | 0.011 
DIV ≥ 5 0.499 | 0.642 | 0.793 0.472 | 0.505 | 0.538 0.969 | 0.975 | 
0.982 
0.988 | 0.993 | 0.996 0.052 | 0.111 | 0.160 0.003 | 0.007 | 0.011 
DIV ≥ 6 0.448 | 0.586 | 0.757 0.472 | 0.506 | 0.539 0.973 | 0.978 | 
0.984 
0.988 | 0.992 | 0.996 0.053 | 0.107 | 0.153 0.003 | 0.007 | 0.011 
DIV ≥ 7 0.375 | 0.514 | 0.703 0.472 | 0.505 | 0.538 0.975 | 0.980 | 
0.985 
0.988 | 0.992 | 0.995 0.044 | 0.093 | 0.136 0.003 | 0.007 | 0.010 
DIV ≥ 8 0.329 | 0.457 | 0.661 0.472 | 0.505 | 0.538 0.978 | 0.983 | 
0.987 
0.988 | 0.991 | 0.995 0.039 | 0.083 | 0.124 0.003 | 0.007 | 0.010 
DIV ≥ 9 0.285 | 0.409 | 0.614 0.472 | 0.505 | 0.538 0.981 | 0.985 | 
0.990 
0.988 | 0.991 | 0.995 0.034 | 0.072 | 0.111 0.003 | 0.006 | 0.009 
DIV ≥ 10 0.201 | 0.320 | 0.570 0.472 | 0.505 | 0.538 0.984 | 0.988 | 
0.991 
0.988 | 0.991 | 0.994 0.022 | 0.052 | 0.088 0.003 | 0.006 | 0.008 
Set of models assuming good clinical mastitis reporting quality  
DIV ≥ 1 0.806 | 0.871 | 0.930 0.872 | 0.893 | 0.912 0.903 | 0.908 | 
0.912 
0.990 | 0.994 | 0.997 0.016 | 0.035 | 0.058 0.002 | 0.006 | 0.010 
DIV ≥ 2 0.797 | 0.868 | 0.928 0.872 | 0.893 | 0.912 0.948 | 0.953 | 
0.957 
0.990 | 0.994 | 0.997 0.016 | 0.035 | 0.058 0.002 | 0.006 | 0.011 
DIV ≥ 3 0.789 | 0.859 | 0.921 0.873 | 0.894 | 0.912 0.959 | 0.963 | 
0.967 
0.990 | 0.994 | 0.997 0.016 | 0.036 | 0.058 0.002 | 0.007 | 0.011 
DIV ≥ 4 0.750 | 0.828 | 0.902 0.873 | 0.894 | 0.913 0.963 | 0.967 | 
0.971 
0.989 | 0.993 | 0.996 0.016 | 0.035 | 0.057 0.003 | 0.007 | 0.012 
DIV ≥ 5 0.697 | 0.790 | 0.873 0.873 | 0.894 | 0.913 0.968 | 0.972 | 
0.975 
0.989 | 0.993 | 0.996 0.016 | 0.034 | 0.055 0.003 | 0.008 | 0.012 
DIV ≥ 6 0.640 | 0.741 | 0.839 0.874 | 0.894 | 0.913 0.971 | 0.975 | 
0.979 
0.989 | 0.992 | 0.996 0.015 | 0.032 | 0.053 0.003 | 0.007 | 0.011 
DIV ≥ 7 0.534 | 0.653 | 0.759 0.874 | 0.894 | 0.913 0.974 | 0.977 | 
0.981 
0.988 | 0.992 | 0.995 0.013 | 0.028 | 0.047 0.003 | 0.007 | 0.010 
DIV ≥ 8 0.469 | 0.595 | 0.708 0.874 | 0.895 | 0.913 0.977 | 0.980 | 
0.983 
0.989 | 0.992 | 0.995 0.012 | 0.026 | 0.044 0.004 | 0.007 | 0.010 
DIV ≥ 9 0.400 | 0.524 | 0.651 0.874 | 0.894 | 0.913 0.981 | 0.983 | 
0.986 
0.989 | 0.992 | 0.995 0.010 | 0.023 | 0.039 0.003 | 0.006 | 0.009 
DIV ≥ 10 0.278 | 0.409 | 0.534 0.874 | 0.894 | 0.913 0.984 | 0.986 | 
0.988 
0.989 | 0.992 | 0.995 0.007 | 0.017 | 0.031 0.004 | 0.006 | 0.008  
a DIV = milk-diversion-day threshold in number of days when milk was diverted from the bulk tank; 
b SeMD = sensitivity, milk diversion; 
c SeRCM = sensitivity, reported clinical mastitis; 
d SpMD = specificity milk diversion; 
e SpRCM = specificity reported clinical mastitis. 
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milk-diversion-day threshold. Generally, we saw adequate tradeoffs 
between specificity and sensitivity at a general threshold of 4 to 7 days, 
depending on the knowledge on the farmer recording ability. 
Choosing an optimal milk-diversion-day threshold would depend on 
the usual length of treatment regimen and the aim of using milk diver-
sion as a proxy for clinical mastitis. Some studies of extended intra-
mammary treatment use treatment durations of 1.5–5 days (Swinkels 
et al., 2014) or 2–8 days (Oliver et al., 2004) without considering 
withdrawal time. In practice, antibiotic treatments of clinical mastitis 
cases are recommended to take longer than 3 days (Pyörälä, 2009) and, 
including withdrawal times, even longer milk-diversion-day thresholds 
could apply. In these cases, our found threshold of 4–7 days would be 
approximately in the range of the above treatment durations. However, 
these milk-diversion-day durations may also be regional or herd specific, 
depending on the recommendations for antibiotic usage. For example, 
differences between conventional and organic farms in terms of number 
of cases treated with antibiotics has been found in some countries 
(Bennedsgaard et al., 2003), but not in others (Fall and Emanuelson, 
2009), which could also influence the milk-diversion-day threshold. 
Hence, the diagnostic properties of milk diversion to detect clinical 
mastitis at specific thresholds depend on the treatment regiments used, 
which may be farm specific. Future work could seek specific 
milk-diversion-duration thresholds for different farm types, times, or 
even types of uses. 
Milk diversion will never be a perfect indicator of clinical mastitis as: 
1) clinical mastitis observations do not always lead to treatments leading 
to milk diversion; 2) milk diversion may occur for other reasons than 
clinical mastitis (e.g. subclinical mastitis or other diseases); and 3) 
clinical mastitis is not always detected by farmers and thus may not be 
treated. Addressing the first point, it should be noted that most cows 
with registered (clinical) mastitis in the United States received antibiotic 
treatment (85.6%) (APHIS, 2016). As such, assuming that farmers follow 
milk withdrawal guidelines, milk diversion would work in most clinical 
cases. Addressing the second point, antibiotic treatments of other dis-
eases in dairy cows during lactation are less frequent than treatments 
due to udder health, at least in Denmark, Sweden, and the Netherlands 
(Høg et al., 2019; Kuipers et al., 2016; Växa Sverige, 2020). Nonetheless, 
the relative proportions of treatments due to mastitis and due to other 
diseases are likely to differ between countries due to different farm 
practices. Nevertheless, the influence of other reasons for diverting milk 
may be limited. To address this, we have tried to implement a model 
with cohort-specific parameters (Bermingham et al., 2015) for the 
different countries in our data, but the model did not converge and we 
could not find more information to incorporate into our prior distribu-
tions to combat the lack of identifiability. Addressing the third point, 
milk diversion would only work when clinical mastitis is detected by the 
farmer. Clinical mastitis is not always detected because farmers may 
miss signs of clinical mastitis, although this seems rare when it comes to 
clots in the milk (Rasmussen, 2005). In AMS, clinical mastitis is not al-
ways detected because not all clinical mastitis cases lead to alerts and 
not all alerts are followed up by farmers, as illustrated by a study finding 
that only 3.5% of alerts were followed up by farmers (Hogeveen et al., 
2013). Milk diversion, therefore, cannot be used to indicate undetected 
clinical mastitis, only observed but unreported clinical mastitis. These 
unreported cases might for instance occur when a cow is not treated for 
mastitis, but culled without a reported reason. In general, milk diversion 
or withdrawal is initiated in connection with the start of antibiotic 
treatment to avoid antibiotic residue in the bulk tank and, when clinical 
mastitis is treated, it is likely reported, as milk diversion is similar in 
sensitivity and specificity to the RCM status found here. 
We used informative priors for the sensitivity and specificity of 
farmer-RCM and herd prevalence in our analyses, but weakly informa-
tive priors for all other parameters. The priors for farmer-recorded pa-
rameters was based on the sensitivity of farmer-RCM reported by Wolff 
et al. (2012) and was used to create two models with different as-
sumptions as to farmer attitude toward detecting and reporting clinical 
mastitis when clinical mastitis can be observed. These priors may not 
have been correct for all regions, as the information for determining the 
priors came from countries not included in the dataset; we had no choice 
in this matter, as we were extremely limited in the available information 
about farmer attitude toward detecting and reporting clinical mastitis. 
Therefore, we used the lowest and highest sensitivity cases presented by 
Wolff et al. (2012) as the scenarios of the sensitivity of farmer-RCM to 
obtain an approximation of the diagnostic properties of RCM under two 
substantially different scenarios in the different countries. 
Changing the priors for farmer-RCM affected all other parameters. 
This can be explained by the need to estimate 8 parameters (2 sensi-
tivity, 2 specificity, 2 prevalence, and 2 covariance parameters) with 8 
data points (4 possible test combinations for 2 populations), essentially 
forcing the model to estimate a relatively large number of parameters for 
a limited number of data points. The use of the conditionally dependent 
model increases the need for prior information (Branscum et al., 2005; 
Kostoulas et al., 2017) as it increases the number of parameters to be 
estimated. This is why two scenarios for the sensitivity of farmer-RCM 
were explored in this study. Examining two different scenarios could 
be helpful, as a researcher may have indications of the data quality of 
specific farms and could use them in determining the milk-diversion-day 
threshold. In both scenarios, milk diversion was on par with RCM cases 
in terms of sensitivity and worse in terms of specificity when using a 
milk-diversion-day threshold of 1–4 days when the farmer’s quality of 
clinical mastitis case reporting was good. Consequently, milk diversion 
at specific milk-diversion-day thresholds is a relatively good indicator of 
clinical mastitis but not as specific as farmer-reported cases, regardless 
of the farmer’s quality of clinical mastitis reporting. 
We also assumed in our Bayesian latent class analysis that the high- 
and low-producing populations would have equal diagnostic properties 
in terms of sensitivities and specificities for diagnosing clinical mastitis. 
Implicitly, we assumed that farmers who primarily have high-producing 
cows would have diagnostic skills similar to those of farmers with low- 
producing cows and that farmers who have both high- and low- 
producing cows would not have any preferential diagnostic and 
recording bias towards high-producing cows. However, this may not be 
the case, as the difference in prevalence of clinical mastitis between 
high- and low-producing cows could partly be because farmers with 
higher-producing cows are more eager to treat and report clinical 
mastitis (Nyman et al., 2007). Many factors could play a role in the 
potential preferential diagnostic biases of farmers; however, research 
into differences in the diagnostic ability of farmers is limited. We did not 
encounter any research that quantified the factors that affect preferen-
tial diagnostic and treatment bias in clinical mastitis. We could not make 
any distinction based on a mastitis indicator (e.g. SCC), as farmers might 
not apply the same diagnostic properties across groups, as they might 
check cows with a high mastitis indicator more thoroughly than cows 
with a low mastitis indicator. The division could not be made on the herd 
level, as it can be expected that the farmers’ skill levels might differ 
between herds. Division on the region level resulted in a very unequal 
distribution of cases between populations and was therefore undesir-
able. Hence, we assumed that there were no differences in diagnostic 
properties, at least globally, between our milk-yield groups. Neverthe-
less, further research is needed to determine the size of these biases in 
diagnosing clinical mastitis and, possibly, to change this view. 
To remove autocorrelation, we randomly sampled one 30 DIM time 
period within each lactation, ran the analysis, and repeated these steps 
300 times. It excluded multiple observations from the same cow and 
therefore removed the cow level autocorrelation. The cow level auto-
correlation could occur when the farmer has observed clinical mastitis 
prior in the lactation. Once a farmer has observed clinical mastitis, the 
farmer will pay more attention to that cow and have a higher sensitivity 
in detecting a new case during the same lactation. To gather overall 
diagnostic properties, we have chosen to take a random sample for each 
lactation. An interesting alternative would be to focus on the first, sec-
ond, and third cases during a lactation separately to determine whether 
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the diagnostic measures change. It is generally unknown how the 
diagnostic abilities of farmers change and this work would investigate 
whether clinical mastitis history is one of the factors that influence 
diagnostic ability. However, this was not the aim of this study, but it 
might be an interesting research avenue to pursue in the future. 
The good diagnostic properties of milk diversion indicate that milk 
diversion at certain thresholds can be used to indicate the clinical 
mastitis status. More specifically, milk diversion could be useful when 
analyzing large databases. The current ways of conducting research on 
clinical mastitis are to: 1) create very small databases in which the re-
searchers detect clinical mastitis cases themselves using very precise 
definitions; 2) carrying out larger studies in which farmers are asked to 
keep track of their mastitis detection results for a certain period, 
potentially based on instructions from the researcher; or 3) create large 
databases in which all veterinary treatments are stored (e.g. as has been 
done in the Scandinavian countries). Option one would be very time 
consuming and costly and is typically used when high precision is 
required. In option two, the farmers might forget to record all the cases 
they detected or, despite the instructions given them about the defini-
tion of clinical mastitis, might deviate in their actual reporting. In option 
three, the clinical mastitis data are not perfect as not all clinical cases 
would be treated and recorded. Using milk diversion, uniform estimates 
can be made over a large number of dairy farmers, routinely, without 
any interference. This would create novel opportunities for “big data”- 
based research or very specific farm-based research. 
5. Conclusions 
Milk diversion may serve as a reasonable indicator of the clinical 
mastitis status of a cow. Overall, we would recommend a milk-diversion- 
day threshold of 4–7 days, as it gave very similar or minimally poorer 
sensitivity and specificity compared with those of recorded mastitis 
cases. The threshold should be determined according to the aim for 
which milk diversion will be used, information on the farmers’ reporting 
quality, and the used treatment regimens. Using milk diversion as an 
indicator of clinical mastitis could be valuable in several areas, including 
estimating herd incidence rates of mastitis, evaluating farmer reporting 
quality, and possibly as a label in clinical mastitis detection algorithms. 
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